Certican Tablets
- Name:
Certican Tablets
- Company:
Novartis Ireland Limited
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may not be renewed (A)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 23/11/20

Click on this link to Download PDF directly
Novartis Ireland Limited

Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 23 November 2020 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
Updated on 23 November 2020 SPC
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 12 May 2020 PIL
Reasons for updating
- Change to section 5 - how to store or dispose
Updated on 20 March 2020 PIL
Reasons for updating
- Change to section 5 - how to store or dispose
Updated on 20 March 2020 SPC
Reasons for updating
- Change to section 6.4 - Special precautions for storage
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 1 November 2019 PIL
Reasons for updating
- Change to section 4 - possible side effects
Updated on 1 November 2019 SPC
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 22 March 2019 PIL
Reasons for updating
- Change to section 4 - how to report a side effect
Updated on 24 July 2018 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 19 May 2016 PIL
Reasons for updating
- New PIL for new product